Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Am J Med Genet C Semin Med Genet. 2012 Feb 15;160C(1):59-68. doi: 10.1002/ajmg.c.31318. Epub 2012 Jan 17.
Pompe disease is an autosomal recessive lysosomal glycogen storage disorder that is caused by acid α-glucosidase (GAA) deficiency and is due to pathogenic sequence variations in the corresponding GAA gene. The correlation between genotypes and phenotypes is strict, in that patients with the most severe phenotype, classic infantile Pompe disease, have two pathogenic mutations, one in each GAA allele, that prevent the formation of GAA or totally obliterates its function. All patients with less progressive phenotypes have at least one sequence variation that allows normal or low level synthesis of GAA leading to the formation of analytically measurable, low level GAA activity in most cases. There is an overall trend of finding higher GAA enzyme levels in patients with onset of symptoms in adulthood when compared to patients who show clinical manifestations in early childhood, aged 0-5 years, with a rapidly progressive course, but who lack the severe characteristics of classic infantile Pompe disease. However, several cases have been reported of adult-onset disease with very low GAA activity, which in all those cases corresponds with the GAA genotype. The clinical diversity observed within a large group of patients with functionally the same GAA genotype and the same c.-32-13C > T haplotype demonstrates that modifying factors can have a substantial effect on the clinical course of Pompe disease, disturbing the GAA genotype-phenotype correlation. The present day challenge is to identify these factors and explore them as therapeutic targets.
庞贝病是一种常染色体隐性溶酶体糖原贮积病,由酸性α-葡萄糖苷酶(GAA)缺乏引起,是由于相应的 GAA 基因发生致病序列变异所致。基因型与表型之间的相关性非常严格,即最严重表型——经典婴儿型庞贝病患者的两个 GAA 等位基因各有一个致病性突变,阻止 GAA 的形成或完全使其丧失功能。所有进展较慢的表型患者至少有一种序列变异,允许正常或低水平合成 GAA,导致在大多数情况下形成可分析测量的、低水平的 GAA 活性。与在 0-5 岁时出现临床表现、疾病进展迅速的早发性婴儿型庞贝病患者相比,成年起病的患者通常具有更高的 GAA 酶水平,这是一个总体趋势,但缺乏经典婴儿型庞贝病的严重特征。然而,已经报道了几例成年起病、GAA 活性非常低的病例,在所有这些病例中,GAA 基因型均符合上述情况。在一群具有相同功能性 GAA 基因型和相同 c.-32-13C > T 单倍型的患者中观察到的临床表现多样性表明,修饰因子对庞贝病的临床病程有实质性影响,干扰了 GAA 基因型-表型相关性。当前的挑战是识别这些因素,并将其作为治疗靶点进行探索。